Our top pick for
National Health Investors, Inc is a reit-healthcare facilities business based in the US. National Health Investors shares (NHI) are listed on the NYSE and all prices are listed in US Dollars. National Health Investors employs 19 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$41.38 - $77.40|
|50-day moving average||$74.10|
|200-day moving average||$67.49|
|Wall St. target price||$70.50|
|Dividend yield||$4.41 (6.02%)|
|Earnings per share (TTM)||$4.14|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing National Health Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of National Health Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
National Health Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, National Health Investors shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
National Health Investors's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.99. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into National Health Investors's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
National Health Investors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $304.9 million.
The EBITDA is a measure of a National Health Investors's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$329.7 million|
|Operating margin TTM||67.27%|
|Gross profit TTM||$320 million|
|Return on assets TTM||4.5%|
|Return on equity TTM||12.27%|
|Market capitalisation||$3.4 billion|
TTM: trailing 12 months
There are currently 1.2 million National Health Investors shares held short by investors – that's known as National Health Investors's "short interest". This figure is 38.3% up from 836,349 last month.
There are a few different ways that this level of interest in shorting National Health Investors shares can be evaluated.
National Health Investors's "short interest ratio" (SIR) is the quantity of National Health Investors shares currently shorted divided by the average quantity of National Health Investors shares traded daily (recently around 373214.19354839). National Health Investors's SIR currently stands at 3.1. In other words for every 100,000 National Health Investors shares traded daily on the market, roughly 3100 shares are currently held short.
However National Health Investors's short interest can also be evaluated against the total number of National Health Investors shares, or, against the total number of tradable National Health Investors shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case National Health Investors's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 National Health Investors shares in existence, roughly 30 shares are currently held short) or 0.0314% of the tradable shares (for every 100,000 tradable National Health Investors shares, roughly 31 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against National Health Investors.
Find out more about how you can short National Health Investors stock.
Dividend payout ratio: 78.78% of net profits
Recently National Health Investors has paid out, on average, around 78.78% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 6.02% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), National Health Investors shareholders could enjoy a 6.02% return on their shares, in the form of dividend payments. In National Health Investors's case, that would currently equate to about $4.41 per share.
National Health Investors's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
National Health Investors's most recent dividend payout was on 6 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 March 2021 (the "ex-dividend date").
Over the last 12 months, National Health Investors's shares have ranged in value from as little as $41.3793 up to $77.3985. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while National Health Investors's is 0.9509. This would suggest that National Health Investors's shares are less volatile than average (for this exchange).
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. .
Everything we know about the TC Bancshares IPO, plus information on how to buy in.
Everything we know about the Soulgate IPO, plus information on how to buy in.
Everything we know about the Alzamend Neuro IPO, plus information on how to buy in.
Everything we know about the Singular Genomics Systems IPO, plus information on how to buy in.
Everything we know about the Golden Sun Education Group Limited IPO, plus information on how to buy in.
Everything we know about the Phillips Edison & Company IPO, plus information on how to buy in.
Everything we know about the FIGS IPO, plus information on how to buy in.
Everything we know about the DLocal Limited IPO, plus information on how to buy in.
Everything we know about the Torchy’s Tacos IPO, plus information on how to buy in.
Everything we know about the Dutch Bros Coffee IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.